SK Biopharm Valuation Analysis (What Is the Market Implying from SK Holdings?)
In this insight, we provide a valuation analysis of SK Biopharmaceuticals (BIO SK).Bullish Case Valuation - If we take a bullish case valuation...
334 Views
TissueGene IPO Part 1 - IPO Prospectus Summary
What is Korea's hottest stock now? I guess many investors will have SillaJen, Inc. (0908477D KS) in their mind when asked this question. SillaJen's...
645 Views
SillaJen's December IPO: Valuation, Growth Expectation and IPO Timing
SillaJen Biotherapeutics (established in 2006) is indeed a rare breed in Korean pharmaceutical world. It is not a generic drug maker. It is not a...
3.4k Views